Bellicum Pharmaceuticals, Inc. (BLCM)
(Delayed Data from NSDQ)
$3.15 USD
+0.13 (4.30%)
Updated May 3, 2019 04:00 PM ET
After-Market: $3.15 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For BLCM
-
Bellicum Reports Third Quarter 2022 Financial Results and Provides Operational Update
-
Bellicum Pharmaceuticals (BLCM) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
-
Bellicum Pharmaceuticals (BLCM) Reports Q3 Loss, Lags Revenue Estimates
-
Earnings Preview: Bellicum Pharmaceuticals (BLCM) Q3 Earnings Expected to Decline
-
Bellicum Pharmaceuticals (BLCM) Reports Q2 Loss, Tops Revenue Estimates
-
Bellicum Pharmaceuticals (BLCM) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
-
Bellicum Pharmaceuticals (BLCM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Bellicum Pharmaceuticals (BLCM) Reports Q1 Loss, Tops Revenue Estimates
-
Bellicum Pharmaceuticals (BLCM) Reports Q3 Loss, Tops Revenue Estimates
-
Will Bellicum Pharmaceuticals (BLCM) Report Negative Earnings Next Week? What You Should Know
-
Bellicum Pharmaceuticals (BLCM) Reports Q2 Loss, Tops Revenue Estimates